Industry News
All Life Sciences & Technology News
Top stories summarized by our editors
Life SciencesLab Sciences
Top stories summarized by our editors
9/23/2020

Scientists at Yerkes National Primate Research Center are developing a COVID-19 vaccine based on what they've learned over the past two decades in pursuit of an HIV vaccine. The researchers have learned how to reprogram the immune system, says study leader Rama Amara, and though the team started working on a COVID-19 vaccine later than many other research labs, they have caught up and have a candidate that harnesses both neutralizing antibodies to block the virus' entry into cells and T cells to kill bits of virus that manage to evade antibodies. Full Story: Emory Brain Health Center (9/9)

Full Story:
emoryhealthcare.org
9/23/2020

Researchers are scaling up a clinical trial of a device that restored vision in blind sheep. A camera sends images wirelessly to processing units implanted in the brain that convert image data to electrical impulses that travel to neurons along implanted microelectrodes.

9/23/2020

Johnson & Johnson launched Phase III of a clinical trial on a single-dose COVID-19 vaccine and expects to report results by the end of the year, according to chief scientific officer Paul Stoffels. The company also posted a detailed clinical trial protocol on its website.

Full Story:
Reuters
9/23/2020

GK Pharmaceuticals Contract Manufacturing Operations has received emergency use authorization from the FDA for its GK Accu-Right SARS-CoV-2 RT-PCR Kit.

9/23/2020

The FDA is poised to release a more stringent set of emergency use authorization standards for potential COVID-19 vaccines, and the rules suggest a vaccine won't be approved under the framework until after the election. Sources say EUA applicants will need to follow participants in Phase III trials for a median of two months or more after they receive a second vaccine shot, and placebo groups will need to include at least five severe COVID-19 cases plus some infections in older adults.

9/23/2020

Patients with decompensated liver cirrhosis and water retention had improved outcomes when treated with tolvaptan, according to a study published in Japan's Journal of Gastroenterology. The retrospective study, which included 100 patients, did not find a difference in prognosis for patients with short-term response, but better prognoses were seen for patients with long-term response, researchers wrote.

More Summaries:
water retention, tolvaptan
9/23/2020

Quest Diagnostics is partnering with Walmart and DroneUp to deliver Quest SARS-CoV-2 home collection kits to residents within a one-mile radius of a Walmart in North Las Vegas using drones. The program will "examine how drones could deliver health care to patients who are unable to leave their home, or live in remote locations," said Dan Haemmerle, Quest Diagnostics' general manager of extended care.

More Summaries:
Quest Diagnostics, Walmart, DroneUp
9/23/2020

William Whealon has been chosen to serve as VP of research & development for Silk Road Medical, effective immediately. Lucas Buchanan, the company's current CFO, has also been chosen to serve as chief operating officer, starting Oct.1.

Full Story:
MassDevice (Boston)
More Summaries:
Silk Road Medical
9/23/2020

Neo Medical has entered an investment and partnership agreement with Orthofix to co-develop a cervical platform with single-use, sterile-packed procedure solutions.

Full Story:
Becker's Spine Review
9/23/2020

A Series C financing round has raised $18 million for Israel-based pain-response monitoring technology developer Medasense Biometrics. "This funding round will allow us to expand and further consolidate commercial deployment of NOL technology in Europe through our distribution agreement with Medtronic and to complete the process of obtaining FDA approval for commercialization in the U.S.," said Galit Zuckerman-Stark, Medasense CEO and founder.

Full Story:
MassDevice (Boston)
More Summaries:
Galit